ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 2 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,413 | -99.9% | 1,910,000 | 0.0% | 0.72% | -4.6% |
| Q3 2022 | $2,409,000 | -51.0% | 1,910,000 | -65.6% | 0.75% | -44.6% |
| Q2 2022 | $4,921,000 | +6.1% | 5,560,000 | 0.0% | 1.36% | +19.9% |
| Q1 2022 | $4,636,000 | -13.5% | 5,560,000 | 0.0% | 1.14% | -6.7% |
| Q4 2021 | $5,362,000 | +6.6% | 5,560,000 | 0.0% | 1.22% | -7.5% |
| Q3 2021 | $5,031,000 | -36.0% | 5,560,000 | -41.8% | 1.32% | -28.5% |
| Q2 2021 | $7,857,000 | -11.2% | 9,560,000 | -9.5% | 1.84% | -14.4% |
| Q1 2021 | $8,851,000 | +12.3% | 10,560,000 | 0.0% | 2.15% | +7.3% |
| Q4 2020 | $7,880,000 | -12.8% | 10,560,000 | 0.0% | 2.00% | -20.3% |
| Q3 2020 | $9,033,000 | -12.7% | 10,560,000 | 0.0% | 2.51% | -10.2% |
| Q2 2020 | $10,343,000 | +33.5% | 10,560,000 | +7.1% | 2.80% | +15.6% |
| Q1 2020 | $7,747,000 | – | 9,860,000 | – | 2.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Indaba Capital Management, L.P. | 22,235,000 | $14,700,000 | 1.93% |
| PenderFund Capital Management Ltd. | 5,560,000 | $4,921,000 | 1.36% |
| Bruce & Co., Inc. | 3,000,000 | $2,040,000 | 0.48% |
| Saltoro Capital, LP | 2,000,000 | $1,360,000 | 0.33% |
| INGALLS & SNYDER LLC | 769,000 | $509,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 4,000,000 | $2,727,000 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 2,750,000 | $1,870,000 | 0.01% |
| Citadel Advisors | 38,655,000 | $25,173,000 | 0.01% |
| CREDIT SUISSE AG/ | 2,000,000 | $2,000,000 | 0.00% |
| JANE STREET GROUP, LLC | 3,000,000 | $1,971,000 | 0.00% |